Journal of Current Pharmacology

About the Journal

The Journal of Current Pharmacology (JCP) is a peer-reviewed, open-access journal dedicated to publishing cutting-edge research in all aspects of pharmacology, including drug discovery, development, mechanisms of action, clinical applications, and regulatory advancements. The journal serves as a platform for researchers, clinicians, and pharmaceutical professionals to share new insights that contribute to the safe and effective use of pharmacological agents in healthcare.

The journal welcomes original research articles, clinical trials, systematic reviews, meta-analyses, and expert perspectives in the following areas:

• Pharmacodynamics & Pharmacokinetics: Mechanisms of drug action, metabolism, bioavailability, and drug interactions.
• Drug Discovery & Development: Screening, lead optimization, and preclinical studies of novel therapeutic agents.
• Clinical Pharmacology & Therapeutics: Studies on drug efficacy, safety, adverse effects, and real-world applications in various diseases.
• Molecular & Cellular Pharmacology: Investigations into drug-receptor interactions, signal transduction, and molecular drug targets.
• Neuropharmacology & Psychopharmacology: Advances in the treatment of neurological and psychiatric disorders.
• Cardiovascular & Metabolic Pharmacology: Research on antihypertensives, anticoagulants, lipid-lowering agents, and diabetes medications.
• Immunopharmacology & Biologics: Innovations in monoclonal antibodies, immunotherapies, and vaccines.
• Oncology & Chemotherapy: Development and clinical applications of anti-cancer drugs, targeted therapies, and personalized medicine approaches.
• Toxicology & Safety Pharmacology: Studies on drug toxicity, poisoning, and regulatory toxicology.
• Natural Products & Pharmacognosy: Research on plant-based compounds, herbal medicines, and nutraceuticals.
• Pharmaceutical Biotechnology & Nanomedicine: Advances in drug delivery systems, gene therapy, and nanotechnology applications.
• Regulatory Science & Pharmacovigilance: Updates on drug approval processes, post-marketing surveillance, and adverse drug reaction reporting.
• Personalized Medicine & Pharmacogenomics: The role of genetic factors in drug response and individualized treatment strategies.
• Antimicrobial & Anti-inflammatory Pharmacology: Studies on antibiotics, antivirals, antifungals, and novel anti-inflammatory agents.

The journal serves pharmacologists, clinicians, biomedical researchers, pharmaceutical scientists, regulatory professionals, and healthcare policymakers involved in drug research and development.

The Journal of Current Pharmacology follows a rigorous peer-review process to ensure the publication of high-quality, impactful research. As an open-access journal, it promotes rapid dissemination of pharmacological knowledge to advance global healthcare and drug development.